Hindustan Bio Sciences Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 395126, "name": "Hind.Bio Science", "stock_name": "Hind.Bio Science", "full_name": "Hindustan Bio Sciences Ltd", "name_url": "stocks-analysis/hindbio-science", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "7.99", "chg": 0.38, "chgp": "4.99%", "dir": 1, "prev_price": "7.61", "mcapval": "8.00 Cr", "mcap": "Micro Cap", "scripcode": 532041, "symbol": "", "ind_name": "Software Products", "ind_code": 4, "indexname": "", "isin": "INE597C01021", "curr_date": "Mar 05", "curr_time": "", "bse_nse_vol": "5.38 k", "exc_status": "Active", "traded_date": "Mar 05, 2026", "traded_date_str": "2026 03 05", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hindbio-science-395126-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Hindustan Bio Sciences Ltd Gains 21.01%: Valuation and Quality Concerns Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/hindustan-bio-sciences-ltd-gains-2101-valuation-and-quality-concerns-shape-the-week-3826722", "imagepath": "", "date": "2026-02-07 17:18:29", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Quality grade downgraded to Below Average, Strong Sell rating assigned</p>\n <p><strong>2 Feb:</strong> Valuation metrics escalated, stock classified as very expensive</p>\n <p><strong>2 Feb:</strong> Stock price surged 10.06% despite Sensex decline</p>\n <p><strong>3-6 Feb:</strong> Mixed daily price movements with overall weekly gain of 21.01%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.7.44</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close..." }, { "title": "Hindustan Bio Sciences Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Expensive Valuation", "link": "https://www.marketsmojo.com/news/stock-recommendation/hindustan-bio-sciences-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-expensive-valuation-3815717", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HindustanBioSci_mojoScore_3815717.png", "date": "2026-02-02 08:19:59", "description": "Hindustan Bio Sciences Ltd has been assigned a Strong Sell rating with a Mojo Score of 21.0, reflecting significant concerns across quality, valuation, financial trends, and technical indicators. The downgrade from a previously ungraded status follows a comprehensive reassessment revealing deteriorating fundamentals, expensive market valuation, and mixed technical signals despite recent price gains." }, { "title": "Hindustan Bio Sciences Ltd Valuation Shifts Signal Elevated Price Risk", "link": "https://www.marketsmojo.com/news/stocks-in-action/hindustan-bio-sciences-ltd-valuation-shifts-signal-elevated-price-risk-3815281", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HindustanBioSci_valuationdot_3815281.png", "date": "2026-02-02 08:01:09", "description": "Hindustan Bio Sciences Ltd, a player in the Software Products sector, has seen a marked shift in its valuation parameters, moving from a risky to a very expensive rating. Despite a strong short-term price rally, the company’s elevated price-to-earnings and price-to-book ratios raise questions about its price attractiveness relative to historical averages and peer benchmarks." }, { "title": "Hindustan Bio Sciences Ltd Quality Grade Downgrade Highlights Fundamental Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/hindustan-bio-sciences-ltd-quality-grade-downgrade-highlights-fundamental-challenges-3815215", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HindustanBioSci_qualitydot_3815215.png", "date": "2026-02-02 08:00:16", "description": "Hindustan Bio Sciences Ltd has seen its quality grade downgraded from \"Does Not Qualify\" to \"Below Average\" as of 1 February 2026, reflecting deteriorations in key business fundamentals. Despite a recent surge in share price, the company’s financial metrics reveal challenges in profitability, capital efficiency, and growth consistency, raising concerns for investors in the Software Products sector." }, { "title": "Hindustan Bio Sciences Q3 FY26: Profitability Returns But Volatility Remains High", "link": "https://www.marketsmojo.com/news/result-analysis/hindustan-bio-sciences-q3-fy26-profitability-returns-but-volatility-remains-high-3815022", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HindustanBioSci_quaterlyResult_3815022.png", "date": "2026-01-31 21:01:08", "description": "Hindustan Bio Sciences Ltd., a micro-cap pharmaceutical company with a market capitalisation of just ₹7.00 crores, posted a net profit of ₹0.08 crores in Q3 FY26 (October-December 2025), marking a sharp recovery from the ₹0.06 crore loss reported in the previous quarter. The stock surged 4.88% to ₹7.09 on February 1, 2026, though it remains 31.30% below its 52-week high of ₹10.32 amid persistent concerns about operational stability and financial sustainability." }, { "title": "When is the next results date for Hindustan Bio Sciences Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-hindustan-bio-sciences-ltd-3797091", "imagepath": "", "date": "2026-01-20 23:16:12", "description": "The next results date for Hindustan Bio Sciences Ltd is scheduled for January 31, 2026...." } ], "total": 99, "sid": "395126", "stock_news_url": "https://www.marketsmojo.com/news/hindustan-bio-sciences-395126" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "02-Feb-2026", "details": "We are hereby submitting the Newspaper Advertisement in Hitech Edition (English Language) and Prajapalana (Telugu Language) regarding Unaudited Standalone financial results for the Third Quarter ended on December 31 2025", "source": "BSE" }, { "caption": "Un-Audited Results For Quarter Ended 31-12-2025", "datetime": "31-Jan-2026", "details": "Un-audited results for quarter ended 31-12-2025", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of Board Meeting", "datetime": "31-Jan-2026", "details": "Outcome of Board Meeting", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Feb: Quality grade downgraded to Below Average, Strong Sell rating assigned

2 Feb: Valuation metrics escalated, stock classified as very expensive

2 Feb: Stock price surged 10.06% despite Sensex decline

3-6 Feb: Mixed daily price movements with overall weekly gain of 21.01%

Week Open

Rs.7.44

Week Close...

Read full news article

Hindustan Bio Sciences Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Expensive Valuation

2026-02-02 08:19:59

Hindustan Bio Sciences Ltd has been assigned a Strong Sell rating with a Mojo Score of 21.0, reflecting significant concerns across quality, valuation, financial trends, and technical indicators. The downgrade from a previously ungraded status follows a comprehensive reassessment revealing deteriorating fundamentals, expensive market valuation, and mixed technical signals despite recent price gains.

Read full news article

Hindustan Bio Sciences Ltd Valuation Shifts Signal Elevated Price Risk

2026-02-02 08:01:09

Hindustan Bio Sciences Ltd, a player in the Software Products sector, has seen a marked shift in its valuation parameters, moving from a risky to a very expensive rating. Despite a strong short-term price rally, the company’s elevated price-to-earnings and price-to-book ratios raise questions about its price attractiveness relative to historical averages and peer benchmarks.

Read full news article

Hindustan Bio Sciences Ltd Quality Grade Downgrade Highlights Fundamental Challenges

2026-02-02 08:00:16

Hindustan Bio Sciences Ltd has seen its quality grade downgraded from "Does Not Qualify" to "Below Average" as of 1 February 2026, reflecting deteriorations in key business fundamentals. Despite a recent surge in share price, the company’s financial metrics reveal challenges in profitability, capital efficiency, and growth consistency, raising concerns for investors in the Software Products sector.

Read full news article

Hindustan Bio Sciences Q3 FY26: Profitability Returns But Volatility Remains High

2026-01-31 21:01:08

Hindustan Bio Sciences Ltd., a micro-cap pharmaceutical company with a market capitalisation of just ₹7.00 crores, posted a net profit of ₹0.08 crores in Q3 FY26 (October-December 2025), marking a sharp recovery from the ₹0.06 crore loss reported in the previous quarter. The stock surged 4.88% to ₹7.09 on February 1, 2026, though it remains 31.30% below its 52-week high of ₹10.32 amid persistent concerns about operational stability and financial sustainability.

Read full news article

When is the next results date for Hindustan Bio Sciences Ltd?

2026-01-20 23:16:12

The next results date for Hindustan Bio Sciences Ltd is scheduled for January 31, 2026....

Read full news article